In this work, we aimed to analyze the knowledge and use of existing technologies and digital support for type 1 and 2 diabetes self-management, which includes smart devices such as glucose meters, CGMs, insulin pumps, or smartphones, as well as software applications focused to monitor blood glucose levels, insulin dosage, diet, and physical activity as main axes involved in diabetes disease from early stages. The gene discussed is INS; the disease is diabetes mellitus.